MEDANTA — Global Health Share Price
Last trade - 00:00- IN₹376.90bn
- IN₹374.74bn
- IN₹26.94bn
- 78
- 4
- 100
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 59.99 | ||
| PEG Ratio (f) | 2.82 | ||
| EPS Growth (f) | 27.04% | ||
| Dividend Yield (f) | 0.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 14.2 | ||
| Price to Tang. Book | 14.22 | ||
| Price to Free Cashflow | 92.26 | ||
| Price to Sales | 11.95 | ||
| EV to EBITDA | 48.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.47% | ||
| Return on Equity | 20.87% | ||
| Operating Margin | 19.05% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 15,004.22 | 14,467.43 | 21,665.89 | 26,942.48 | 33,260.83 | 38,864.5 | 21.55% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -21.91 | +584.36 | +73.67 | +46.33 | +27.04 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 13th, 2004
- Public Since
- November 16th, 2022
- No. of Shareholders
- 107,120
- No. of Employees
- 9,350
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 268,507,382
- Address
- E-18, Defence Colony, NEW DELHI, 110024
- Web
- https://www.medanta.org/
- Phone
- +91 1244834060
- Contact
- Rahul Ranjan
- Auditors
- Walker Chandiok & Co LLP
Similar to MEDANTA
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Dr. Lal PathLabs
National Stock Exchange of India
FAQ
As of Today at 19:09 UTC, shares in Global Health are trading at IN₹1,403.70. This share price information is delayed by 15 minutes.
Shares in Global Health last closed at IN₹1,403.70 and the price had moved by +184.18% over the past 365 days. In terms of relative price strength the Global Health share price has outperformed the S&P BSE 100 Index by +120.41% over the past year.
The overall consensus recommendation for Global Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Global Health does not currently pay a dividend.
Global Health does not currently pay a dividend.
Global Health does not currently pay a dividend.
To buy shares in Global Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,403.70, shares in Global Health had a market capitalisation of IN₹376.90bn.
Here are the trading details for Global Health:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: MEDANTA
Based on an overall assessment of its quality, value and momentum Global Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Global Health is IN₹1,326.71. That is 5.48% below the last closing price of IN₹1,403.70.
Analysts covering Global Health currently have a consensus Earnings Per Share (EPS) forecast of IN₹18.42 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Health. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +56.06%.
As of the last closing price of IN₹1,403.70, shares in Global Health were trading +47.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Global Health PE ratio based on its reported earnings over the past 12 months is 59.99. The shares last closed at IN₹1,403.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Global Health's directors